USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India

The United States Food and Drugs Administration ('USFDA') has conducted an inspection at the manufacturing facility of Medispray Laboratories Private Limited, wholly owned subsidiary of Cipla Limited (Medispray) located in Kundaim, Goa from 14th - 20th January, 2025. On conclusion of the inspection, Medispray received one observation in Form 483. The company will work closely with the USFDA and remains committed to address these observations comprehensively within stipulated time.

IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited has informed that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for 'MESALAZINE' on 16th January 2025. This certification will enable the company to export this product in European and other CEP accepting countries. Mesalazine is used to treat inflammatory bowel disease.